Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Laurie Millar"'
Autor:
Paul Emery, William Rigby, Paul P Tak, Thomas Dörner, Ewa Olech, Carmen Martin, Laurie Millar, Helen Travers, Elena Fisheleva
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e87379 (2014)
ObjectiveThe objective was to determine the safety of ocrelizumab (OCR) in patients with rheumatoid arthritis (RA).MethodsThis was an analysis of the double-blind, placebo-controlled periods and long-term follow-up of 4 OCR phase III trials in RA (SC
Externí odkaz:
https://doaj.org/article/49652c7e07ca420993dde7e84ab236dd
Autor:
Howard Mackey, Laurie Millar, Kaycee M Sink, Helen Lin, Susanne Ostrowitzki, Francis Warren, Paulo Fontoura, Jillian Smith, Susan Yule, Angelica Quartino, Rachelle Doody, Andres Schneider, Reina N. Fuji, Michael Rabbia
Publikováno v:
Alzheimer's & Dementia. 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b8ecc8eff68f5a4c59685eb2dd62b5d
https://doi.org/10.1016/j.jalz.2018.06.2339
https://doi.org/10.1016/j.jalz.2018.06.2339
Autor:
Laurie Millar, Carol Reid, Nakao Iwata, Shitij Kapur, Tiago Reis Marques, Snjezana Sameljak, Dragana Bugarski-Kirola, Thomas Blaettler, George Garibaldi
Publikováno v:
The lancet. Psychiatry. 3(12)
Summary Background Many patients with schizophrenia require high doses of medication for their ongoing psychotic symptoms. Glutamate theories and findings from studies showing efficacy of sarcosine, an endogenous, non-selective glycine-reuptake inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::300cba131feaaf6b90142615a083e753
https://pubmed.ncbi.nlm.nih.gov/27816569
https://pubmed.ncbi.nlm.nih.gov/27816569
Publikováno v:
Annals of the New York Academy of Sciences. 978
A recent model of cerebellar learning in eyeblink conditioning predicts two sites of plasticity, the cerebellar cortex and cerebellar nuclei, which store information relating to timing and driving the movement, respectively. Consistent with this idea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78daeea9cbf97c4f50289a509884061f
https://pubmed.ncbi.nlm.nih.gov/12582043
https://pubmed.ncbi.nlm.nih.gov/12582043
Autor:
William F. C. Rigby, Elena Fisheleva, Paul P. Tak, Laurie Millar, Helen Travers, Carmen Martin, Paul Emery, Thomas Dörner, Ewa Olech
Publikováno v:
PLoS ONE, 9(2). Public Library of Science
PLoS ONE
PLoS ONE, Vol 9, Iss 2, p e87379 (2014)
PLoS ONE
PLoS ONE, Vol 9, Iss 2, p e87379 (2014)
Objective The objective was to determine the safety of ocrelizumab (OCR) in patients with rheumatoid arthritis (RA). Methods This was an analysis of the double-blind, placebo-controlled periods and long-term follow-up of 4 OCR phase III trials in RA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcca0623aca564eaeaeb584050911fdf
https://doi.org/10.1371/journal.pone.0087379
https://doi.org/10.1371/journal.pone.0087379